Quadria Capital buys 10% stake in pharma company Aragen Life Sciences for $100 million

Aragen Life Sciences secured a $100 million investment from Quadria Capital, selling a 10% stake at a $1.4 billion valuation. This funding supports strategic expansion to meet demand from US and European innovators. Aragen revenue for FY24 and FY25 is projected at Rs 1,675 crore and Rs 1,800 crore respectively.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FWuwnEJ
via IFTTT